Enlivex Therapeutics Ltd. (ENLV) vs Ensysce Biosciences, Inc. (ENSC)
A side-by-side comparison of Enlivex Therapeutics Ltd. and Ensysce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENLV
Enlivex Therapeutics Ltd.
$0.36HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT
ENSC
Ensysce Biosciences, Inc.
$0.42HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT
Total return — ENLV vs ENSC
growth of $100 · dividends reinvested · last 9yENLV -99.9% (-53.4%/yr)ENSC -100.0% (-71.6%/yr)ENLV compounded faster over this window
Log scale — wide-divergence pair
ENLV ENSC
ENLV vs ENSC: by the numbers
- •ENSC is the larger company ($6M vs $6M market cap).
- •Both run net losses; ENLV's is the smaller (0.00% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | ENLV | ENSC |
|---|---|---|
| P/E ratio | 0.00 | N/A |
| P/S ratio | N/A | 5.49 |
| P/B ratio | 0.00 | N/A |
Profitability
| Metric | ENLV | ENSC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -1084.23% |
| ROE | 105.35% | N/A |
| ROIC | -0.32% | N/A |
Growth (annualized)
| Metric | ENLV | ENSC |
|---|---|---|
| Total return CAGR (5Y) | -69.81% | -86.22% |
Frequently asked
- How have ENLV and ENSC total returns compared?
- Over the past 5 years, ENLV delivered -69.81% and ENSC delivered -86.22% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Enlivex Therapeutics ROEEnsysce Biosciences ROEEnlivex Therapeutics operating marginEnsysce Biosciences operating marginEnlivex Therapeutics revenue growthEnsysce Biosciences revenue growthEnlivex Therapeutics free cash flowEnsysce Biosciences free cash flow
Enlivex Therapeutics & Ensysce Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.